204 related articles for article (PubMed ID: 11216555)
21. The standard peritoneal permeability analysis in the rabbit: a longitudinal model for peritoneal dialysis.
Zweers MM; Douma CE; de Waart DR; van der Wardt AB; Ho-dac-Pannekeet MM; Krediet RT; Struijk DG
Perit Dial Int; 1999; 19(1):56-64. PubMed ID: 10201342
[TBL] [Abstract][Full Text] [Related]
22. The effect of oxidative stress inhibition with trimetazidine on the peritoneal alterations induced by hypertonic peritoneal dialysis solution.
Günal AI; Celiker H; Ustundag B; Akpolat N; Dogukan A; Akcicek F
J Nephrol; 2003; 16(2):225-30. PubMed ID: 12768069
[TBL] [Abstract][Full Text] [Related]
23. Icodextrin metabolism and alpha-amylase activity in nonuremic rats undergoing chronic peritoneal dialysis.
García-López E; Pawlaczyk K; Anderstam B; Qureshi AR; Kuzlan-Pawlaczyk M; Heimbürger O; Werynski A; Lindholm B
Perit Dial Int; 2007; 27(4):415-23. PubMed ID: 17602150
[TBL] [Abstract][Full Text] [Related]
24. Comparison of peritoneal equilibration test with 2.27% and 3.86% glucose dialysis solution.
Cara M; Virga G; Mastrosimone S; Girotto A; Rossi V; D'Angelo A; Bonfante L
J Nephrol; 2005; 18(1):67-71. PubMed ID: 15772925
[TBL] [Abstract][Full Text] [Related]
25. A multinational clinical validation study of PD ADEQUEST 2.0. PD ADEQUEST International Study Group.
Vonesh EF; Story KO; O'Neill WT
Perit Dial Int; 1999; 19(6):556-71. PubMed ID: 10641777
[TBL] [Abstract][Full Text] [Related]
26. Dialysate to plasma solute concentration (D/P) versus peritoneal transport parameters in CAPD.
Heimbürger O; Waniewski J; Werynski A; Park MS; Lindholm B
Nephrol Dial Transplant; 1994; 9(1):47-59. PubMed ID: 8177476
[TBL] [Abstract][Full Text] [Related]
27. Differences in peritoneal equilibration test results in patients aged above or below 60 years.
Grzegorzewska AE; Leander M; Mariak I
Adv Perit Dial; 2002; 18():33-9. PubMed ID: 12402583
[TBL] [Abstract][Full Text] [Related]
28. Bone metabolism and peritoneal membrane transport in children on chronic peritoneal dialysis.
Ziólkowska H; Pańczyk-Tomaszewska M; Debiński A; Sawicki A; Roszkowska-Blaim M
Perit Dial Int; 2003; 23(5):487-92. PubMed ID: 14604203
[TBL] [Abstract][Full Text] [Related]
29. The influence of bicarbonate/lactate-buffered PD fluids on N{ε}-(carboxyethyl)lysine and N{ε}-(carboxymethyl)lysine in peritoneal effluent.
Cnossen TT; Gladziwa U; van de Kerkhof JJ; Schalkwijk CG; Scheijen J; van Amersfoort J; Moret K; Beerenhout CH; Kooman JP
Perit Dial Int; 2011; 31(2):189-93. PubMed ID: 20671103
[TBL] [Abstract][Full Text] [Related]
30. Peritoneal function and adequacy calculations: current programs versus PD Adequest 2.0.
Teixidó-Planas J
Perit Dial Int; 2002; 22(3):386-93. PubMed ID: 12227398
[TBL] [Abstract][Full Text] [Related]
31. Can N-acetylcysteine preserve peritoneal function and morphology in encapsulating peritoneal sclerosis?
Bozkurt D; Hur E; Ulkuden B; Sezak M; Nar H; Purclutepe O; Sen S; Duman S
Perit Dial Int; 2009 Feb; 29 Suppl 2():S202-5. PubMed ID: 19270218
[TBL] [Abstract][Full Text] [Related]
32. Glycated albumin in serum and dialysate of patients on continuous ambulatory peritoneal dialysis.
Lamb E; Cattell WR; Dawnay A
Clin Sci (Lond); 1993 Jun; 84(6):619-26. PubMed ID: 8334808
[TBL] [Abstract][Full Text] [Related]
33. Structural and functional alterations of the peritoneum after prolonged exposure to dialysis solutions: role of aminoguanidine.
Lee EA; Oh JH; Lee HA; Kim SI; Park EW; Park KB; Park MS
Perit Dial Int; 2001; 21(3):245-53. PubMed ID: 11475339
[TBL] [Abstract][Full Text] [Related]
34. Advanced glycation and lipidoxidation of the peritoneal membrane: respective roles of serum and peritoneal fluid reactive carbonyl compounds.
Miyata T; Horie K; Ueda Y; Fujita Y; Izuhara Y; Hirano H; Uchida K; Saito A; van Ypersele de Strihou C; Kurokawa K
Kidney Int; 2000 Jul; 58(1):425-35. PubMed ID: 10886591
[TBL] [Abstract][Full Text] [Related]
35. Analysis of non enzymatic glycosylation in vivo: impact of different dialysis solutions.
Ho-dac-Pannekeet MM; Weiss MF; de Waart DR; Erhard P; Hiralall JK; Krediet RT
Perit Dial Int; 1999; 19 Suppl 2():S68-74. PubMed ID: 10406497
[TBL] [Abstract][Full Text] [Related]
36. Advanced glycation end-products in the peritoneal fluid and in the peritoneal membrane of continuous ambulant peritoneal dialysis patients.
Mahiout A; Ehlerding G; Brunkhorst R
Nephrol Dial Transplant; 1996; 11 Suppl 5():2-6. PubMed ID: 9044298
[TBL] [Abstract][Full Text] [Related]
37. Effects of anaesthesia on fluid and solute transport in a C57BL6 mouse model of peritoneal dialysis.
Shin SK; Kamerath CD; Gilson JF; Leypoldt JK
Nephrol Dial Transplant; 2006 Oct; 21(10):2874-80. PubMed ID: 16877489
[TBL] [Abstract][Full Text] [Related]
38. Intraperitoneal atrial natriuretic peptide increases peritoneal fluid and solute removal.
Wang T; Cheng HH; Heimbürger O; Chen C; Bergström J; Lindholm B
Kidney Int; 2001 Aug; 60(2):513-9. PubMed ID: 11473634
[TBL] [Abstract][Full Text] [Related]
39. Peritoneal transport during dialysis with amino acid-based solutions.
Park MS; Heimbürger O; Bergström J; Waniewski J; Werynski A; Lindholm B
Perit Dial Int; 1993; 13(4):280-8. PubMed ID: 8241328
[TBL] [Abstract][Full Text] [Related]
40. A comparison between 1.36% and 3.86% glucose dialysis solution for the assessment of peritoneal membrane function.
Smit W; Langedijk MJ; Schouten N; van den Berg N; Struijk DG; Krediet RT
Perit Dial Int; 2000; 20(6):734-41. PubMed ID: 11216568
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
